PPP2R2B: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Target Name: PPP2R2B

NCBI ID: G5521

PPP2R2B

PPP2R2B: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of brain cells, leading to a range of symptoms and cognitive impairments. These conditions are often treated with drugs that aim to slow down or halt the progression of neurodegeneration. However, the underlying causes of these diseases are not always fully understood, and new drug targets are always desirable to improve treatment outcomes.

PPP2R2B, a protein phosphatase 2 regulatory subunit beta (PPA), has been identified as a potential drug target and biomarker for neurodegenerative disorders. In this article, we will discuss the structure, function, and potential therapeutic applications of PPP2R2B, as well as its potential as a drug target and biomarker.

Structure and Function

PPP2R2B is a protein that is expressed in various tissues and cell types, including brain, heart, and muscle. Its full name is protein phosphatase 2 regulatory subunit beta, and its transcript variant is 3. PPP2R2B is a 126- amino acid protein with a calculated molecular mass of 17.9 kDa.

PPP2R2B plays a critical role in the regulation of protein phosphatases (PPPs), which are enzymes that remove phosphate groups from other proteins. PPP2R2B is a regulatory subunit of the PPA enzyme, which is responsible for regulating the activity of PPs.

PPP2R2B is involved in a wide range of cellular processes, including cell signaling, protein folding, and intracellular signaling. It has been shown to play a role in various cellular processes, including the regulation of neurotransmitter release, cell proliferation, and apoptosis.

In addition to its role in protein phosphatasing, PPP2R2B has also been shown to play a critical role in the regulation of ion channels and voltage-dependent ion channels (VDCs). This may have important implications for the treatment of neurodegenerative diseases, as disruptions in ion channels have been implicated in the development of these conditions.

Potential Therapeutic Applications

The identification of PPP2R2B as a potential drug target and biomarker for neurodegenerative diseases has significant implications for the development of new treatments. If PPP2R2B is effective as a drug target, it may be possible to develop small molecules or other compounds that specifically target PPP2R2B and inhibit its activity.

In addition to its potential as a drug target, PPP2R2B has also been identified as a potential biomarker for neurodegenerative diseases. The loss of PPP2R2B has been observed in various neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease. This suggests that PPP2R2B may be a useful biomarker for these conditions.

Future Research

While the identification of PPP2R2B as a potential drug target and biomarker for neurodegenerative diseases is an exciting development, much research is still needed to fully understand its function and potential therapeutic applications.

Future studies will focus on the characterization of PPP2R2B as a drug target and biomarker. This will involve a combination of techniques, including biochemical, cellular, and mass spectrometry approaches.

Furthermore, researchers will work to develop small molecules or other compounds that specifically target PPP2R2B and inhibit its activity. This will be an important step in the development of new treatments for neurodegenerative diseases.

Conclusion

PPP2R2B is a protein that has been identified as a potential drug target and biomarker for

Protein Name: Protein Phosphatase 2 Regulatory Subunit Bbeta

Functions: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. Within the PP2A holoenzyme complex, isoform 2 is required to promote proapoptotic activity (By similarity). Isoform 2 regulates neuronal survival through the mitochondrial fission and fusion balance (By similarity)

The "PPP2R2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP2R2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets